Personal tools

FF:10008-101B6: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 37: Line 37:
|id=FF:10008-101B6
|id=FF:10008-101B6
|is_a=EFO:0002091;;FF:0000004;;FF:0000103;;FF:0000343;;UBERON:0000479
|is_a=EFO:0002091;;FF:0000004;;FF:0000103;;FF:0000343;;UBERON:0000479
|is_obsolete=
|name=Universal RNA - Mouse Normal Tissues Biochain, pool1
|name=Universal RNA - Mouse Normal Tissues Biochain, pool1
|namespace=FANTOM5
|namespace=FANTOM5
Line 69: Line 70:
|sample_ethnicity=
|sample_ethnicity=
|sample_experimental_condition=
|sample_experimental_condition=
|sample_gostat=GO:0044464;cell part;0!GO:0005622;intracellular;0!GO:0044424;intracellular part;7.46992100277985e-285!GO:0005737;cytoplasm;5.37404497511534e-187!GO:0044444;cytoplasmic part;2.64666269684433e-146!GO:0043227;membrane-bound organelle;1.31156809254411e-98!GO:0043231;intracellular membrane-bound organelle;1.31156809254411e-98!GO:0043226;organelle;1.29614982989098e-91!GO:0043229;intracellular organelle;2.27751010529499e-91!GO:0044422;organelle part;1.29760063803816e-70!GO:0044446;intracellular organelle part;2.49304934452194e-69!GO:0005515;protein binding;1.48841268121233e-67!GO:0005739;mitochondrion;1.61870492256829e-61!GO:0044237;cellular metabolic process;1.54416981096145e-57!GO:0044238;primary metabolic process;1.32785055452382e-53!GO:0031090;organelle membrane;2.75531775683061e-51!GO:0009058;biosynthetic process;4.7654289601482e-41!GO:0032991;macromolecular complex;4.91917644459102e-41!GO:0044429;mitochondrial part;2.1858209826857e-40!GO:0043233;organelle lumen;1.90596077746375e-39!GO:0031974;membrane-enclosed lumen;1.90596077746375e-39!GO:0030529;ribonucleoprotein complex;3.27996269916542e-39!GO:0019538;protein metabolic process;2.80261730276012e-37!GO:0005783;endoplasmic reticulum;4.45558207630002e-37!GO:0044249;cellular biosynthetic process;6.73519884479733e-35!GO:0044260;cellular macromolecule metabolic process;5.31754051079132e-33!GO:0005829;cytosol;6.86565387295978e-33!GO:0044267;cellular protein metabolic process;1.5815024906932e-31!GO:0003723;RNA binding;2.11377012044245e-31!GO:0016491;oxidoreductase activity;5.43755490244726e-31!GO:0031967;organelle envelope;5.62444838032612e-31!GO:0031975;envelope;1.19279138017849e-30!GO:0033036;macromolecule localization;7.61975850211044e-30!GO:0015031;protein transport;5.63967850285998e-29!GO:0006412;translation;9.6414852114145e-29!GO:0045184;establishment of protein localization;2.91008503514012e-28!GO:0043170;macromolecule metabolic process;4.09261787581334e-28!GO:0008104;protein localization;8.13750377535582e-28!GO:0044432;endoplasmic reticulum part;1.48028054048631e-27!GO:0009059;macromolecule biosynthetic process;9.54635428459664e-27!GO:0016043;cellular component organization and biogenesis;1.83129047569803e-26!GO:0005840;ribosome;3.00714098142152e-26!GO:0005740;mitochondrial envelope;1.36194326309988e-25!GO:0006082;organic acid metabolic process;2.38399974341202e-25!GO:0031966;mitochondrial membrane;3.28072941965294e-25!GO:0019752;carboxylic acid metabolic process;1.41010901981064e-24!GO:0019866;organelle inner membrane;2.1321668266889e-24!GO:0044428;nuclear part;3.45007503855753e-24!GO:0012505;endomembrane system;5.64098291110158e-24!GO:0044248;cellular catabolic process;1.9485096711456e-23!GO:0005743;mitochondrial inner membrane;2.01518798762524e-23!GO:0003735;structural constituent of ribosome;1.29054890782908e-22!GO:0005789;endoplasmic reticulum membrane;1.89943127187344e-22!GO:0042175;nuclear envelope-endoplasmic reticulum network;2.46222832313423e-22!GO:0046907;intracellular transport;6.53395513875638e-22!GO:0006950;response to stress;1.74317694164866e-21!GO:0044255;cellular lipid metabolic process;2.32183482616166e-21!GO:0006629;lipid metabolic process;2.84333807503569e-21!GO:0031980;mitochondrial lumen;1.55905090693986e-20!GO:0005759;mitochondrial matrix;1.55905090693986e-20!GO:0006886;intracellular protein transport;2.09694423196982e-20!GO:0033279;ribosomal subunit;2.32388679562588e-20!GO:0043234;protein complex;4.80376235065462e-20!GO:0006091;generation of precursor metabolites and energy;2.36397257070569e-19!GO:0016071;mRNA metabolic process;3.46693233749501e-19!GO:0008380;RNA splicing;7.50579067432954e-19!GO:0009056;catabolic process;1.11835043794192e-17!GO:0009055;electron carrier activity;2.77520519507339e-17!GO:0006119;oxidative phosphorylation;5.13033547094936e-17!GO:0048770;pigment granule;6.79482633276789e-17!GO:0042470;melanosome;6.79482633276789e-17!GO:0065003;macromolecular complex assembly;6.93618789225658e-17!GO:0032787;monocarboxylic acid metabolic process;2.17248303014166e-16!GO:0006396;RNA processing;1.05022263688411e-15!GO:0006397;mRNA processing;1.13047231491538e-15!GO:0008134;transcription factor binding;1.74914037639139e-15!GO:0031981;nuclear lumen;2.92948788376724e-15!GO:0051186;cofactor metabolic process;3.49177961654939e-15!GO:0005830;cytosolic ribosome (sensu Eukaryota);4.98722815702508e-15!GO:0022607;cellular component assembly;5.5254915229708e-15!GO:0016192;vesicle-mediated transport;5.81621415631333e-14!GO:0006457;protein folding;5.89502627714754e-14!GO:0051641;cellular localization;1.2073586019411e-13!GO:0005681;spliceosome;1.75384980899282e-13!GO:0051649;establishment of cellular localization;2.07089084627797e-13!GO:0044445;cytosolic part;6.59624532181937e-13!GO:0008219;cell death;6.86382340729828e-13!GO:0016265;death;6.86382340729828e-13!GO:0044265;cellular macromolecule catabolic process;8.33256759579155e-13!GO:0006118;electron transport;1.66005336274316e-12!GO:0012501;programmed cell death;1.693117078191e-12!GO:0006915;apoptosis;1.78242247768353e-12!GO:0002526;acute inflammatory response;2.04056841220224e-12!GO:0005794;Golgi apparatus;2.60448764566308e-12!GO:0044455;mitochondrial membrane part;3.15222440758724e-12!GO:0048523;negative regulation of cellular process;3.53794943535562e-12!GO:0009611;response to wounding;4.37800539894511e-12!GO:0005746;mitochondrial respiratory chain;4.68373366115867e-12!GO:0015935;small ribosomal subunit;5.83424337719236e-12!GO:0048037;cofactor binding;6.41561232759232e-12!GO:0006732;coenzyme metabolic process;6.57383235470266e-12!GO:0005773;vacuole;8.24950419192052e-12!GO:0048519;negative regulation of biological process;1.0195956337534e-11!GO:0016655;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;1.39015781766642e-11!GO:0016874;ligase activity;1.44131233607433e-11!GO:0051603;proteolysis involved in cellular protein catabolic process;2.92445462967981e-11!GO:0006605;protein targeting;3.71393952300719e-11!GO:0005792;microsome;4.18613214893171e-11!GO:0019941;modification-dependent protein catabolic process;5.82323323032291e-11!GO:0043632;modification-dependent macromolecule catabolic process;5.82323323032291e-11!GO:0050136;NADH dehydrogenase (quinone) activity;6.2758825945683e-11!GO:0003954;NADH dehydrogenase activity;6.2758825945683e-11!GO:0008137;NADH dehydrogenase (ubiquinone) activity;6.2758825945683e-11!GO:0006511;ubiquitin-dependent protein catabolic process;6.8560976156155e-11!GO:0042598;vesicular fraction;8.3153910789204e-11!GO:0006807;nitrogen compound metabolic process;8.32666557383416e-11!GO:0008202;steroid metabolic process;8.68387866563805e-11!GO:0044257;cellular protein catabolic process;9.11100810806044e-11!GO:0022618;protein-RNA complex assembly;1.09174421122576e-10!GO:0051082;unfolded protein binding;1.1094350333767e-10!GO:0005634;nucleus;1.41961960946433e-10!GO:0000323;lytic vacuole;1.52708387681832e-10!GO:0005764;lysosome;1.52708387681832e-10!GO:0022613;ribonucleoprotein complex biogenesis and assembly;1.55453777510341e-10!GO:0005654;nucleoplasm;1.86318466053837e-10!GO:0009057;macromolecule catabolic process;2.58745261482378e-10!GO:0005793;ER-Golgi intermediate compartment;4.45330995744439e-10!GO:0000502;proteasome complex (sensu Eukaryota);5.63968478322052e-10!GO:0002541;activation of plasma proteins during acute inflammatory response;7.16260987810462e-10!GO:0006956;complement activation;7.16260987810462e-10!GO:0051246;regulation of protein metabolic process;9.95193718127672e-10!GO:0008610;lipid biosynthetic process;1.11138917882184e-09!GO:0003712;transcription cofactor activity;1.4793139980921e-09!GO:0048193;Golgi vesicle transport;1.65545239629298e-09!GO:0006066;alcohol metabolic process;1.68069414544687e-09!GO:0043285;biopolymer catabolic process;1.86709989803612e-09!GO:0016651;oxidoreductase activity, acting on NADH or NADPH;1.95101183700175e-09!GO:0006958;complement activation, classical pathway;1.95601691148782e-09!GO:0015934;large ribosomal subunit;2.1078037168801e-09!GO:0006631;fatty acid metabolic process;2.4246721197389e-09!GO:0050662;coenzyme binding;3.32419296251639e-09!GO:0030964;NADH dehydrogenase complex (quinone);3.84120868979917e-09!GO:0045271;respiratory chain complex I;3.84120868979917e-09!GO:0005747;mitochondrial respiratory chain complex I;3.84120868979917e-09!GO:0006461;protein complex assembly;3.89387310942736e-09!GO:0005768;endosome;4.32949965928596e-09!GO:0042775;organelle ATP synthesis coupled electron transport;4.47258676534364e-09!GO:0042773;ATP synthesis coupled electron transport;4.47258676534364e-09!GO:0009308;amine metabolic process;5.40267991777989e-09!GO:0005843;cytosolic small ribosomal subunit (sensu Eukaryota);6.1729275135946e-09!GO:0008135;translation factor activity, nucleic acid binding;6.4448290258681e-09!GO:0002455;humoral immune response mediated by circulating immunoglobulin;6.56393537119665e-09!GO:0006120;mitochondrial electron transport, NADH to ubiquinone;7.3949117951762e-09!GO:0030163;protein catabolic process;1.02759922130147e-08!GO:0046961;hydrogen ion transporting ATPase activity, rotational mechanism;1.5827074803859e-08!GO:0016614;oxidoreductase activity, acting on CH-OH group of donors;1.63500283427319e-08!GO:0043069;negative regulation of programmed cell death;1.63830711464678e-08!GO:0044451;nucleoplasm part;1.69190698806085e-08!GO:0006520;amino acid metabolic process;1.73734043536544e-08!GO:0043066;negative regulation of apoptosis;2.04991879606118e-08!GO:0016125;sterol metabolic process;2.56779025807645e-08!GO:0006446;regulation of translational initiation;2.9996927922789e-08!GO:0000166;nucleotide binding;3.26744907502041e-08!GO:0016627;oxidoreductase activity, acting on the CH-CH group of donors;3.46559758286304e-08!GO:0006519;amino acid and derivative metabolic process;3.46559758286304e-08!GO:0016817;hydrolase activity, acting on acid anhydrides;3.6517930721803e-08!GO:0006913;nucleocytoplasmic transport;3.70472482279657e-08!GO:0016818;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;4.24949764283093e-08!GO:0016616;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;4.4959739322032e-08!GO:0005761;mitochondrial ribosome;4.8070042376279e-08!GO:0000313;organellar ribosome;4.8070042376279e-08!GO:0016044;membrane organization and biogenesis;4.92165222585355e-08!GO:0016462;pyrophosphatase activity;5.15087551129054e-08!GO:0051169;nuclear transport;8.63165124155342e-08!GO:0042981;regulation of apoptosis;1.36010308097346e-07!GO:0031988;membrane-bound vesicle;1.49318443374209e-07!GO:0017111;nucleoside-triphosphatase activity;1.72571446179551e-07!GO:0031982;vesicle;1.77246613920812e-07!GO:0046933;hydrogen ion transporting ATP synthase activity, rotational mechanism;1.87666805441028e-07!GO:0006996;organelle organization and biogenesis;2.1656198059772e-07!GO:0008203;cholesterol metabolic process;2.31366398486456e-07!GO:0005777;peroxisome;2.53416358674136e-07!GO:0042579;microbody;2.53416358674136e-07!GO:0008565;protein transporter activity;2.55618539072591e-07!GO:0043067;regulation of programmed cell death;2.74916968905807e-07!GO:0016564;transcription repressor activity;2.7747442943394e-07!GO:0015986;ATP synthesis coupled proton transport;2.88602510669138e-07!GO:0015985;energy coupled proton transport, down electrochemical gradient;2.88602510669138e-07!GO:0016023;cytoplasmic membrane-bound vesicle;3.25096084659484e-07!GO:0051187;cofactor catabolic process;3.43259144779961e-07!GO:0006916;anti-apoptosis;3.50198890867682e-07!GO:0031410;cytoplasmic vesicle;4.05860576525131e-07!GO:0005842;cytosolic large ribosomal subunit (sensu Eukaryota);4.24168773754291e-07!GO:0006413;translational initiation;4.61741725281172e-07!GO:0003743;translation initiation factor activity;5.43063391303314e-07!GO:0051789;response to protein stimulus;5.74921514706258e-07!GO:0006986;response to unfolded protein;5.74921514706258e-07!GO:0045333;cellular respiration;6.3000323479833e-07!GO:0007599;hemostasis;6.69468441073526e-07!GO:0030036;actin cytoskeleton organization and biogenesis;7.63399742639967e-07!GO:0007596;blood coagulation;8.52952350388605e-07!GO:0017038;protein import;9.72787169862371e-07!GO:0044262;cellular carbohydrate metabolic process;9.90841264053286e-07!GO:0009060;aerobic respiration;1.01501659745538e-06!GO:0002253;activation of immune response;1.46523368056022e-06!GO:0015980;energy derivation by oxidation of organic compounds;1.48466345488798e-06!GO:0005635;nuclear envelope;1.57204090352961e-06!GO:0016604;nuclear body;1.65043115554965e-06!GO:0006954;inflammatory response;1.81886434004811e-06!GO:0000398;nuclear mRNA splicing, via spliceosome;1.82169088496342e-06!GO:0000375;RNA splicing, via transesterification reactions;1.82169088496342e-06!GO:0000377;RNA splicing, via transesterification reactions with bulged adenosine as nucleophile;1.82169088496342e-06!GO:0009605;response to external stimulus;1.99172195865811e-06!GO:0019829;cation-transporting ATPase activity;1.99976466420245e-06!GO:0042060;wound healing;2.00064814647297e-06!GO:0006512;ubiquitin cycle;2.08606143265038e-06!GO:0050817;coagulation;2.14642918884886e-06!GO:0042221;response to chemical stimulus;2.23739271089871e-06!GO:0006752;group transfer coenzyme metabolic process;2.26113413492839e-06!GO:0019899;enzyme binding;2.26132314388655e-06!GO:0006869;lipid transport;2.28071909752287e-06!GO:0006366;transcription from RNA polymerase II promoter;2.35037821353538e-06!GO:0016607;nuclear speck;2.44098886078695e-06!GO:0010467;gene expression;2.61494800305896e-06!GO:0006099;tricarboxylic acid cycle;2.6184403093438e-06!GO:0046356;acetyl-CoA catabolic process;2.6184403093438e-06!GO:0048518;positive regulation of biological process;2.9354551516011e-06!GO:0030029;actin filament-based process;3.10825573319567e-06!GO:0003714;transcription corepressor activity;3.24804418498974e-06!GO:0008361;regulation of cell size;3.49767074970883e-06!GO:0031324;negative regulation of cellular metabolic process;3.59445882231222e-06!GO:0006694;steroid biosynthetic process;3.74646117021709e-06!GO:0016049;cell growth;3.93219328439155e-06!GO:0009109;coenzyme catabolic process;3.969581776797e-06!GO:0007243;protein kinase cascade;4.05186493677409e-06!GO:0016469;proton-transporting two-sector ATPase complex;4.35627659389633e-06!GO:0051188;cofactor biosynthetic process;5.04490504988176e-06!GO:0043122;regulation of I-kappaB kinase/NF-kappaB cascade;5.06485698435385e-06!GO:0008639;small protein conjugating enzyme activity;5.38921090892192e-06!GO:0005319;lipid transporter activity;5.68334622515196e-06!GO:0031252;leading edge;5.68334622515196e-06!GO:0008092;cytoskeletal protein binding;6.3899402960531e-06!GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB cascade;6.47103405386978e-06!GO:0004842;ubiquitin-protein ligase activity;6.59855062130988e-06!GO:0042802;identical protein binding;8.46823591114979e-06!GO:0006957;complement activation, alternative pathway;8.63870435677151e-06!GO:0006084;acetyl-CoA metabolic process;8.82330221032035e-06!GO:0001558;regulation of cell growth;9.12691544877835e-06!GO:0005506;iron ion binding;9.4738510709457e-06!GO:0016064;immunoglobulin mediated immune response;9.51856825114649e-06!GO:0046034;ATP metabolic process;9.94913059699786e-06!GO:0006897;endocytosis;1.03427560172663e-05!GO:0010324;membrane invagination;1.03427560172663e-05!GO:0006754;ATP biosynthetic process;1.03531841154106e-05!GO:0006753;nucleoside phosphate metabolic process;1.03531841154106e-05!GO:0009892;negative regulation of metabolic process;1.10782045874513e-05!GO:0015078;hydrogen ion transmembrane transporter activity;1.19091073607643e-05!GO:0005788;endoplasmic reticulum lumen;1.19091073607643e-05!GO:0019439;aromatic compound catabolic process;1.19528317147964e-05!GO:0009199;ribonucleoside triphosphate metabolic process;1.20141731398556e-05!GO:0016879;ligase activity, forming carbon-nitrogen bonds;1.30346325492069e-05!GO:0044270;nitrogen compound catabolic process;1.33309184829196e-05!GO:0019787;small conjugating protein ligase activity;1.45968280462935e-05!GO:0009063;amino acid catabolic process;1.48833927803464e-05!GO:0006888;ER to Golgi vesicle-mediated transport;1.59193527538224e-05!GO:0051170;nuclear import;1.70106511125536e-05!GO:0005770;late endosome;1.70997121318485e-05!GO:0046483;heterocycle metabolic process;1.71216840650605e-05!GO:0009142;nucleoside triphosphate biosynthetic process;1.77622648481737e-05!GO:0009201;ribonucleoside triphosphate biosynthetic process;1.77622648481737e-05!GO:0009205;purine ribonucleoside triphosphate metabolic process;1.88628486725409e-05!GO:0009144;purine nucleoside triphosphate metabolic process;1.88628486725409e-05!GO:0006606;protein import into nucleus;2.1205448925471e-05!GO:0019724;B cell mediated immunity;2.36769478489959e-05!GO:0005730;nucleolus;2.52173493284225e-05!GO:0009141;nucleoside triphosphate metabolic process;2.57408486842689e-05!GO:0017076;purine nucleotide binding;2.78281425312935e-05!GO:0000267;cell fraction;2.83556402347659e-05!GO:0009206;purine ribonucleoside triphosphate biosynthetic process;2.86564228948395e-05!GO:0009145;purine nucleoside triphosphate biosynthetic process;2.86564228948395e-05!GO:0030120;vesicle coat;3.04865188875708e-05!GO:0030662;coated vesicle membrane;3.04865188875708e-05!GO:0046930;pore complex;3.07633659840569e-05!GO:0046983;protein dimerization activity;3.60158100316705e-05!GO:0001666;response to hypoxia;3.8472406487848e-05!GO:0008286;insulin receptor signaling pathway;4.05344535054308e-05!GO:0048475;coated membrane;4.19813937405124e-05!GO:0030117;membrane coat;4.19813937405124e-05!GO:0009259;ribonucleotide metabolic process;4.28122285143847e-05!GO:0009310;amine catabolic process;4.56527492559309e-05!GO:0006613;cotranslational protein targeting to membrane;5.01031235635329e-05!GO:0016126;sterol biosynthetic process;5.01031235635329e-05!GO:0003713;transcription coactivator activity;5.10830456528936e-05!GO:0007249;I-kappaB kinase/NF-kappaB cascade;5.24522540117159e-05!GO:0006163;purine nucleotide metabolic process;5.60064903738726e-05!GO:0016787;hydrolase activity;6.32170363336321e-05!GO:0016853;isomerase activity;6.41974556215098e-05!GO:0016628;oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor;6.89039958018706e-05!GO:0048522;positive regulation of cellular process;7.53287782542122e-05!GO:0005839;proteasome core complex (sensu Eukaryota);7.87718001067949e-05!GO:0009108;coenzyme biosynthetic process;8.15599180810287e-05!GO:0009150;purine ribonucleotide metabolic process;8.58310271173263e-05!GO:0001944;vasculature development;8.58330788924926e-05!GO:0000096;sulfur amino acid metabolic process;9.31894354041326e-05!GO:0005624;membrane fraction;9.77201157717337e-05!GO:0065008;regulation of biological quality;0.000108831300527001!GO:0019842;vitamin binding;0.000113539599921309!GO:0006695;cholesterol biosynthetic process;0.000113646955567775!GO:0031965;nuclear membrane;0.00011424838527691!GO:0006006;glucose metabolic process;0.000127435016055874!GO:0043412;biopolymer modification;0.000133753370591305!GO:0015077;monovalent inorganic cation transmembrane transporter activity;0.000137400385863102!GO:0044440;endosomal part;0.000141221534792921!GO:0010008;endosome membrane;0.000141221534792921!GO:0051287;NAD binding;0.00014172508823645!GO:0005791;rough endoplasmic reticulum;0.000154645195342951!GO:0045259;proton-transporting ATP synthase complex;0.000158888601827162!GO:0001568;blood vessel development;0.000159653464144324!GO:0015918;sterol transport;0.000203797688122094!GO:0030301;cholesterol transport;0.000203797688122094!GO:0030867;rough endoplasmic reticulum membrane;0.000205167716893961!GO:0043228;non-membrane-bound organelle;0.000206399662148445!GO:0043232;intracellular non-membrane-bound organelle;0.000206399662148445!GO:0006793;phosphorus metabolic process;0.000209406992625771!GO:0006796;phosphate metabolic process;0.000209406992625771!GO:0003779;actin binding;0.000223612005500097!GO:0006164;purine nucleotide biosynthetic process;0.000228399347485892!GO:0006417;regulation of translation;0.000239024761923427!GO:0006464;protein modification process;0.000241371810602318!GO:0010035;response to inorganic substance;0.000249832576069606!GO:0016881;acid-amino acid ligase activity;0.00025603380980102!GO:0044431;Golgi apparatus part;0.000276169932775192!GO:0016769;transferase activity, transferring nitrogenous groups;0.000306816203552612!GO:0003924;GTPase activity;0.000307768953395508!GO:0008652;amino acid biosynthetic process;0.000328003481806243!GO:0009260;ribonucleotide biosynthetic process;0.000328003481806243!GO:0016887;ATPase activity;0.000328003481806243!GO:0031202;RNA splicing factor activity, transesterification mechanism;0.000331908670598979!GO:0005579;membrane attack complex;0.000344782345985111!GO:0009152;purine ribonucleotide biosynthetic process;0.000351373789112438!GO:0016563;transcription activator activity;0.000363729693198674!GO:0019318;hexose metabolic process;0.000364183946069064!GO:0005996;monosaccharide metabolic process;0.000364183946069064!GO:0043283;biopolymer metabolic process;0.000373698649135722!GO:0031326;regulation of cellular biosynthetic process;0.00038250644427218!GO:0032553;ribonucleotide binding;0.000383291384269286!GO:0032555;purine ribonucleotide binding;0.000383291384269286!GO:0050878;regulation of body fluid levels;0.000422754251683979!GO:0040008;regulation of growth;0.000437278567889529!GO:0006612;protein targeting to membrane;0.000454442483616191!GO:0007264;small GTPase mediated signal transduction;0.000454922041840049!GO:0004298;threonine endopeptidase activity;0.000454922041840049!GO:0016481;negative regulation of transcription;0.000469290413269418!GO:0009889;regulation of biosynthetic process;0.00050122274458286!GO:0006979;response to oxidative stress;0.000503384311689939!GO:0005525;GTP binding;0.000545013873414184!GO:0006508;proteolysis;0.000559973181002392!GO:0045786;negative regulation of progression through cell cycle;0.000582751331794523!GO:0006959;humoral immune response;0.000596202525294406!GO:0008654;phospholipid biosynthetic process;0.000598843329746399!GO:0050789;regulation of biological process;0.000664002317355859!GO:0005741;mitochondrial outer membrane;0.000725288019606605!GO:0005798;Golgi-associated vesicle;0.000758767607989268!GO:0005975;carbohydrate metabolic process;0.000768382880317884!GO:0031968;organelle outer membrane;0.000768382880317884!GO:0009074;aromatic amino acid family catabolic process;0.000780528304980648!GO:0043687;post-translational protein modification;0.000789515870158419!GO:0022890;inorganic cation transmembrane transporter activity;0.000804451242331896!GO:0010033;response to organic substance;0.000812639048054162!GO:0030139;endocytic vesicle;0.000814219467293434!GO:0000097;sulfur amino acid biosynthetic process;0.000842242897068842!GO:0043566;structure-specific DNA binding;0.000842537172872842!GO:0008250;oligosaccharyl transferase complex;0.000845422081085237!GO:0004579;dolichyl-diphosphooligosaccharide-protein glycotransferase activity;0.000896314684060409!GO:0019867;outer membrane;0.000918865343352593!GO:0032446;protein modification by small protein conjugation;0.000918865343352593!GO:0046394;carboxylic acid biosynthetic process;0.000939283637917777!GO:0016053;organic acid biosynthetic process;0.000939283637917777!GO:0016765;transferase activity, transferring alkyl or aryl (other than methyl) groups;0.000963352503894115!GO:0044453;nuclear membrane part;0.000978196574755252!GO:0048471;perinuclear region of cytoplasm;0.000983650424057455!GO:0000245;spliceosome assembly;0.00104123309352825!GO:0004857;enzyme inhibitor activity;0.0011554270676991!GO:0030100;regulation of endocytosis;0.00117524860994833!GO:0016567;protein ubiquitination;0.00120592321555331!GO:0045934;negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.00122540581007341!GO:0030133;transport vesicle;0.00124128368499514!GO:0015931;nucleobase, nucleoside, nucleotide and nucleic acid transport;0.00130646249393227!GO:0004576;oligosaccharyl transferase activity;0.00133103474224431!GO:0030554;adenyl nucleotide binding;0.00140569970187609!GO:0016705;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;0.00143170001911801!GO:0042623;ATPase activity, coupled;0.0015048354573877!GO:0030212;hyaluronan metabolic process;0.00150966812358401!GO:0065007;biological regulation;0.00154041596173322!GO:0008206;bile acid metabolic process;0.00174480692392526!GO:0006518;peptide metabolic process;0.00175477213851732!GO:0045261;proton-transporting ATP synthase complex, catalytic core F(1);0.00177038013734334!GO:0016310;phosphorylation;0.00177481397811038!GO:0042625;ATPase activity, coupled to transmembrane movement of ions;0.00189939639765178!GO:0051920;peroxiredoxin activity;0.00196688768212989!GO:0006487;protein amino acid N-linked glycosylation;0.00206729084261403!GO:0009719;response to endogenous stimulus;0.00214279954321622!GO:0051659;maintenance of mitochondrion localization;0.00215276218743443!GO:0051657;maintenance of organelle localization;0.00215276218743443!GO:0019395;fatty acid oxidation;0.00218415546050022!GO:0001726;ruffle;0.0021913437158706!GO:0006953;acute-phase response;0.00219610431982556!GO:0016903;oxidoreductase activity, acting on the aldehyde or oxo group of donors;0.0022265636074606!GO:0006643;membrane lipid metabolic process;0.00227994172076278!GO:0045792;negative regulation of cell size;0.00234489080582131!GO:0033116;ER-Golgi intermediate compartment membrane;0.00243747056240184!GO:0033178;proton-transporting two-sector ATPase complex, catalytic domain;0.00252820302824898!GO:0016408;C-acyltransferase activity;0.002581661097979!GO:0030308;negative regulation of cell growth;0.00260688268220971!GO:0006725;aromatic compound metabolic process;0.00261704142527626!GO:0043021;ribonucleoprotein binding;0.00265484556738843!GO:0032561;guanyl ribonucleotide binding;0.00266590380073093!GO:0019001;guanyl nucleotide binding;0.00266590380073093!GO:0009069;serine family amino acid metabolic process;0.00266895736826269!GO:0033673;negative regulation of kinase activity;0.0027687057288564!GO:0006469;negative regulation of protein kinase activity;0.0027687057288564!GO:0048514;blood vessel morphogenesis;0.0027687057288564!GO:0051427;hormone receptor binding;0.0027687057288564!GO:0006558;L-phenylalanine metabolic process;0.00279243711354965!GO:0006559;L-phenylalanine catabolic process;0.00279243711354965!GO:0001525;angiogenesis;0.00281400108138202!GO:0030532;small nuclear ribonucleoprotein complex;0.00283387963705415!GO:0051270;regulation of cell motility;0.00283772436976524!GO:0003690;double-stranded DNA binding;0.00295012255708776!GO:0019843;rRNA binding;0.00296541248598091!GO:0050794;regulation of cellular process;0.00299675121747661!GO:0019838;growth factor binding;0.00310156986282477!GO:0004364;glutathione transferase activity;0.00310156986282477!GO:0005885;Arp2/3 protein complex;0.00315105912672191!GO:0005159;insulin-like growth factor receptor binding;0.00338870874577792!GO:0048468;cell development;0.00343774297556774!GO:0016197;endosome transport;0.00345972637746815!GO:0010038;response to metal ion;0.00353814397618851!GO:0008483;transaminase activity;0.00357059368514274!GO:0000139;Golgi membrane;0.00362320945992671!GO:0050657;nucleic acid transport;0.00362320945992671!GO:0051236;establishment of RNA localization;0.00362320945992671!GO:0050658;RNA transport;0.00362320945992671!GO:0006357;regulation of transcription from RNA polymerase II promoter;0.00362320945992671!GO:0016679;oxidoreductase activity, acting on diphenols and related substances as donors;0.00362320945992671!GO:0016681;oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor;0.00362320945992671!GO:0008121;ubiquinol-cytochrome-c reductase activity;0.00362320945992671!GO:0030027;lamellipodium;0.00362320945992671!GO:0006635;fatty acid beta-oxidation;0.00366308295967802!GO:0055088;lipid homeostasis;0.0037178454346301!GO:0016859;cis-trans isomerase activity;0.00401226507895802!GO:0016860;intramolecular oxidoreductase activity;0.00409208278112317!GO:0005762;mitochondrial large ribosomal subunit;0.00409208278112317!GO:0000315;organellar large ribosomal subunit;0.00409208278112317!GO:0002449;lymphocyte mediated immunity;0.00429175682878343!GO:0031960;response to corticosteroid stimulus;0.00438722176840639!GO:0002684;positive regulation of immune system process;0.00440011774172165!GO:0005774;vacuolar membrane;0.00442958080849571!GO:0006403;RNA localization;0.00446958150621143!GO:0018196;peptidyl-asparagine modification;0.00451879033016531!GO:0018279;protein amino acid N-linked glycosylation via asparagine;0.00451879033016531!GO:0035257;nuclear hormone receptor binding;0.00453850080482515!GO:0005643;nuclear pore;0.0046971778861068!GO:0044242;cellular lipid catabolic process;0.00471605702424134!GO:0016829;lyase activity;0.00474631006428962!GO:0045454;cell redox homeostasis;0.00477797341923301!GO:0045892;negative regulation of transcription, DNA-dependent;0.00483724747345329!GO:0003857;3-hydroxyacyl-CoA dehydrogenase activity;0.00485501535579704!GO:0002250;adaptive immune response;0.00485501535579704!GO:0002460;adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains;0.00485501535579704!GO:0004300;enoyl-CoA hydratase activity;0.00489955623137682!GO:0000151;ubiquitin ligase complex;0.00502673899044077!GO:0003755;peptidyl-prolyl cis-trans isomerase activity;0.00512586754056337!GO:0006693;prostaglandin metabolic process;0.00512586754056337!GO:0006692;prostanoid metabolic process;0.00512586754056337!GO:0007005;mitochondrion organization and biogenesis;0.00512586754056337!GO:0055086;nucleobase, nucleoside and nucleotide metabolic process;0.00512902056158762!GO:0016740;transferase activity;0.00513319685951381!GO:0009966;regulation of signal transduction;0.00514851690108434!GO:0003724;RNA helicase activity;0.00573159251218889!GO:0051540;metal cluster binding;0.00611964800624101!GO:0051536;iron-sulfur cluster binding;0.00611964800624101!GO:0005577;fibrinogen complex;0.00633917615219964!GO:0005769;early endosome;0.00645954635146555!GO:0051348;negative regulation of transferase activity;0.0065228947425094!GO:0050778;positive regulation of immune response;0.00713544713341641!GO:0009725;response to hormone stimulus;0.00751375958266763!GO:0016591;DNA-directed RNA polymerase II, holoenzyme;0.007600426536732!GO:0048500;signal recognition particle;0.00790693861801071!GO:0006879;cellular iron ion homeostasis;0.00791112056512409!GO:0055072;iron ion homeostasis;0.00791112056512409!GO:0005753;mitochondrial proton-transporting ATP synthase complex;0.00793886612758112!GO:0050660;FAD binding;0.00801459766982757!GO:0005905;coated pit;0.00833008787661899!GO:0042157;lipoprotein metabolic process;0.00834352999637022!GO:0051235;maintenance of localization;0.00848007280672402!GO:0000314;organellar small ribosomal subunit;0.00866791581360874!GO:0005763;mitochondrial small ribosomal subunit;0.00866791581360874!GO:0065002;intracellular protein transport across a membrane;0.00866791581360874!GO:0051087;chaperone binding;0.00892231492399916!GO:0030118;clathrin coat;0.00895888084483957!GO:0065009;regulation of a molecular function;0.00917490168953935!GO:0006644;phospholipid metabolic process;0.00925436534167986!GO:0030218;erythrocyte differentiation;0.00944884434965813!GO:0003697;single-stranded DNA binding;0.00954255507904283!GO:0045926;negative regulation of growth;0.00967312678837748!GO:0002682;regulation of immune system process;0.00974126044857536!GO:0008209;androgen metabolic process;0.00974887152387806!GO:0051128;regulation of cellular component organization and biogenesis;0.00985815701974564!GO:0009967;positive regulation of signal transduction;0.00985815701974564!GO:0015405;P-P-bond-hydrolysis-driven transmembrane transporter activity;0.00992584881110343!GO:0015399;primary active transmembrane transporter activity;0.00992584881110343!GO:0005524;ATP binding;0.0100475717839097!GO:0008047;enzyme activator activity;0.0100475717839097!GO:0006790;sulfur metabolic process;0.0101522889160909!GO:0030132;clathrin coat of coated pit;0.0106310564450974!GO:0002443;leukocyte mediated immunity;0.0111125850386839!GO:0040011;locomotion;0.0111682988138782!GO:0051252;regulation of RNA metabolic process;0.011222242306783!GO:0019210;kinase inhibitor activity;0.0113329601675268!GO:0040012;regulation of locomotion;0.0113329601675268!GO:0032559;adenyl ribonucleotide binding;0.0115233796856964!GO:0006767;water-soluble vitamin metabolic process;0.0116259725460833!GO:0005083;small GTPase regulator activity;0.0116504815018137!GO:0051384;response to glucocorticoid stimulus;0.0116608803856083!GO:0006650;glycerophospholipid metabolic process;0.0116625263780105!GO:0009081;branched chain family amino acid metabolic process;0.0117689700540174!GO:0008154;actin polymerization and/or depolymerization;0.0118209766022753!GO:0051101;regulation of DNA binding;0.0122954604352418!GO:0016876;ligase activity, forming aminoacyl-tRNA and related compounds;0.0126076737411523!GO:0004812;aminoacyl-tRNA ligase activity;0.0126076737411523!GO:0016875;ligase activity, forming carbon-oxygen bonds;0.0126076737411523!GO:0030134;ER to Golgi transport vesicle;0.0126759584244512!GO:0002252;immune effector process;0.0127652578814941!GO:0030041;actin filament polymerization;0.0132374423105222!GO:0051179;localization;0.0132524350280178!GO:0009991;response to extracellular stimulus;0.0133423351989604!GO:0051248;negative regulation of protein metabolic process;0.0135680865816524!GO:0005667;transcription factor complex;0.0138767341786182!GO:0031589;cell-substrate adhesion;0.0144963397007763!GO:0004177;aminopeptidase activity;0.0144963397007763!GO:0006525;arginine metabolic process;0.0146532312192074!GO:0030127;COPII vesicle coat;0.0154061873633785!GO:0012507;ER to Golgi transport vesicle membrane;0.0154061873633785!GO:0043623;cellular protein complex assembly;0.0154182545074568!GO:0006614;SRP-dependent cotranslational protein targeting to membrane;0.0155512487431221!GO:0045047;protein targeting to ER;0.0155512487431221!GO:0004860;protein kinase inhibitor activity;0.0155849771110983!GO:0030530;heterogeneous nuclear ribonucleoprotein complex;0.0155899285818057!GO:0007040;lysosome organization and biogenesis;0.0156329845076932!GO:0009117;nucleotide metabolic process;0.0157316706896731!GO:0035258;steroid hormone receptor binding;0.0158528571867976!GO:0044437;vacuolar part;0.016130673408342!GO:0015036;disulfide oxidoreductase activity;0.0162868228121075!GO:0008201;heparin binding;0.0166290505360489!GO:0006706;steroid catabolic process;0.0168495901367284!GO:0007050;cell cycle arrest;0.0169026658208344!GO:0043038;amino acid activation;0.0169026658208344!GO:0006418;tRNA aminoacylation for protein translation;0.0169026658208344!GO:0043039;tRNA aminoacylation;0.0169026658208344!GO:0007265;Ras protein signal transduction;0.0170986734110162!GO:0043492;ATPase activity, coupled to movement of substances;0.0171537143311421!GO:0006778;porphyrin metabolic process;0.0171537143311421!GO:0033013;tetrapyrrole metabolic process;0.0171537143311421!GO:0016676;oxidoreductase activity, acting on heme group of donors, oxygen as acceptor;0.0171537143311421!GO:0015002;heme-copper terminal oxidase activity;0.0171537143311421!GO:0016675;oxidoreductase activity, acting on heme group of donors;0.0171537143311421!GO:0004129;cytochrome-c oxidase activity;0.0171537143311421!GO:0043488;regulation of mRNA stability;0.0172041211592454!GO:0043487;regulation of RNA stability;0.0172041211592454!GO:0016709;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NADH or NADPH as one donor, and incorporation of one atom of oxygen;0.0173894463146422!GO:0006572;tyrosine catabolic process;0.0174240790273508!GO:0016820;hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances;0.0175084235940649!GO:0016862;intramolecular oxidoreductase activity, interconverting keto- and enol-groups;0.0176475972542998!GO:0006402;mRNA catabolic process;0.0179728005740223!GO:0031667;response to nutrient levels;0.0182930954154893!GO:0031072;heat shock protein binding;0.0182994123409098!GO:0016712;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;0.0182994123409098!GO:0055092;sterol homeostasis;0.0185149393151752!GO:0042632;cholesterol homeostasis;0.0185149393151752!GO:0004029;aldehyde dehydrogenase (NAD) activity;0.0185329334962003!GO:0030170;pyridoxal phosphate binding;0.0186472178280376!GO:0005852;eukaryotic translation initiation factor 3 complex;0.0189702118612644!GO:0006633;fatty acid biosynthetic process;0.0191858464455598!GO:0051591;response to cAMP;0.0193420141520093!GO:0046364;monosaccharide biosynthetic process;0.0194012798962036!GO:0046165;alcohol biosynthetic process;0.0194012798962036!GO:0017166;vinculin binding;0.0198857867253276!GO:0051028;mRNA transport;0.0199032840005828!GO:0043284;biopolymer biosynthetic process;0.0201566758748502!GO:0008186;RNA-dependent ATPase activity;0.0201784150188178!GO:0006702;androgen biosynthetic process;0.0201968520242056!GO:0051168;nuclear export;0.0202838914731814!GO:0048659;smooth muscle cell proliferation;0.0202838914731814!GO:0042626;ATPase activity, coupled to transmembrane movement of substances;0.0202838914731814!GO:0016780;phosphotransferase activity, for other substituted phosphate groups;0.0206181748184286!GO:0005786;signal recognition particle, endoplasmic reticulum targeting;0.020651906578437!GO:0051674;localization of cell;0.0207528608789785!GO:0006928;cell motility;0.0207528608789785!GO:0005520;insulin-like growth factor binding;0.0211466027709537!GO:0001887;selenium metabolic process;0.0216928279453989!GO:0042627;chylomicron;0.0218742075247714!GO:0016877;ligase activity, forming carbon-sulfur bonds;0.0221351274010242!GO:0008026;ATP-dependent helicase activity;0.0222210577092456!GO:0019904;protein domain specific binding;0.0222704304980348!GO:0007162;negative regulation of cell adhesion;0.0223974738222647!GO:0050811;GABA receptor binding;0.0223974738222647!GO:0003988;acetyl-CoA C-acyltransferase activity;0.0223974738222647!GO:0003729;mRNA binding;0.0226178739494533!GO:0006259;DNA metabolic process;0.0226178739494533!GO:0050776;regulation of immune response;0.0228425658582559!GO:0043681;protein import into mitochondrion;0.0228433846905189!GO:0005765;lysosomal membrane;0.023116653837023!GO:0016791;phosphoric monoester hydrolase activity;0.0232840966973261!GO:0005048;signal sequence binding;0.0235256262007471!GO:0045893;positive regulation of transcription, DNA-dependent;0.0239352490945377!GO:0042026;protein refolding;0.0240458067425557!GO:0007160;cell-matrix adhesion;0.0243873310272382!GO:0030658;transport vesicle membrane;0.0246603846504434!GO:0051726;regulation of cell cycle;0.0247546459166863!GO:0009066;aspartate family amino acid metabolic process;0.0252153124636969!GO:0050748;negative regulation of lipoprotein metabolic process;0.0252272200500039!GO:0000074;regulation of progression through cell cycle;0.0254456956749442!GO:0031227;intrinsic to endoplasmic reticulum membrane;0.0255517345401183!GO:0031327;negative regulation of cellular biosynthetic process;0.0260114352797901!GO:0045637;regulation of myeloid cell differentiation;0.0262079988566736!GO:0048487;beta-tubulin binding;0.0262646855822661!GO:0005665;DNA-directed RNA polymerase II, core complex;0.0270326177574274!GO:0042168;heme metabolic process;0.0272035035515608!GO:0033344;cholesterol efflux;0.0272855381600819!GO:0006607;NLS-bearing substrate import into nucleus;0.0272855381600819!GO:0031902;late endosome membrane;0.0273088336541781!GO:0050749;apolipoprotein E receptor binding;0.0276194291916616!GO:0030518;steroid hormone receptor signaling pathway;0.0276340566426266!GO:0006890;retrograde vesicle-mediated transport, Golgi to ER;0.0278127401654411!GO:0003746;translation elongation factor activity;0.0278480382606596!GO:0006139;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.0284559339335695!GO:0030176;integral to endoplasmic reticulum membrane;0.0285409959501704!GO:0046904;calcium oxalate binding;0.0286451618904833!GO:0030568;plasmin inhibitor activity;0.0286451618904833!GO:0015923;mannosidase activity;0.0288518031955188!GO:0030193;regulation of blood coagulation;0.0294197473962222!GO:0016836;hydro-lyase activity;0.0299701389628505!GO:0000041;transition metal ion transport;0.0300490409393548!GO:0003995;acyl-CoA dehydrogenase activity;0.0300908377528223!GO:0008312;7S RNA binding;0.0303290759007259!GO:0046467;membrane lipid biosynthetic process;0.0305193897672042!GO:0007010;cytoskeleton organization and biogenesis;0.0305333506423629!GO:0051537;2 iron, 2 sulfur cluster binding;0.0305967812050454!GO:0015682;ferric iron transport;0.0307567671909983!GO:0015091;ferric iron transmembrane transporter activity;0.0307567671909983!GO:0031643;positive regulation of myelination;0.0307567671909983!GO:0030119;AP-type membrane coat adaptor complex;0.0309375107980815!GO:0042803;protein homodimerization activity;0.0312678509063781!GO:0005938;cell cortex;0.0317588020576052!GO:0007033;vacuole organization and biogenesis;0.0317588020576052!GO:0019319;hexose biosynthetic process;0.0319363899915171!GO:0000122;negative regulation of transcription from RNA polymerase II promoter;0.0319831245456694!GO:0016229;steroid dehydrogenase activity;0.0324428725393658!GO:0042254;ribosome biogenesis and assembly;0.0327193632409581!GO:0030663;COPI coated vesicle membrane;0.0337412281291194!GO:0030126;COPI vesicle coat;0.0337412281291194!GO:0030155;regulation of cell adhesion;0.0337893281588789!GO:0051346;negative regulation of hydrolase activity;0.0339646817867721!GO:0042558;pteridine and derivative metabolic process;0.0340014670692938!GO:0004197;cysteine-type endopeptidase activity;0.0343201289795925!GO:0007242;intracellular signaling cascade;0.0346716791454078!GO:0006749;glutathione metabolic process;0.0353525462873986!GO:0051539;4 iron, 4 sulfur cluster binding;0.0353525462873986!GO:0051098;regulation of binding;0.0355474479491895!GO:0016667;oxidoreductase activity, acting on sulfur group of donors;0.0358685778543418!GO:0006892;post-Golgi vesicle-mediated transport;0.0361995400095021!GO:0006509;membrane protein ectodomain proteolysis;0.0362554169341896!GO:0033619;membrane protein proteolysis;0.0362554169341896!GO:0030131;clathrin adaptor complex;0.0362554169341896!GO:0046686;response to cadmium ion;0.0363433373397523!GO:0000060;protein import into nucleus, translocation;0.0374021813556913!GO:0008430;selenium binding;0.0374840109907818!GO:0016620;oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor;0.0376466693352839!GO:0017015;regulation of transforming growth factor beta receptor signaling pathway;0.0377103750523752!GO:0006414;translational elongation;0.037813632120388!GO:0030569;chymotrypsin inhibitor activity;0.0379624489044481!GO:0006090;pyruvate metabolic process;0.0379981082380219!GO:0051271;negative regulation of cell motility;0.03802565828534!GO:0016281;eukaryotic translation initiation factor 4F complex;0.0381197921549064!GO:0030695;GTPase regulator activity;0.0389511703669631!GO:0008139;nuclear localization sequence binding;0.0393116215161935!GO:0006081;aldehyde metabolic process;0.0401181582172746!GO:0030334;regulation of cell migration;0.0401181582172746!GO:0005099;Ras GTPase activator activity;0.0408486301688178!GO:0016746;transferase activity, transferring acyl groups;0.0408486301688178!GO:0050818;regulation of coagulation;0.0410015561250108!GO:0000050;urea cycle;0.0413169738015183!GO:0043603;amide metabolic process;0.0413169738015183!GO:0019627;urea metabolic process;0.0413169738015183!GO:0006818;hydrogen transport;0.0416106514715459!GO:0004386;helicase activity;0.0417534231960878!GO:0003702;RNA polymerase II transcription factor activity;0.0417538432728872!GO:0046395;carboxylic acid catabolic process;0.0424770059291789!GO:0016054;organic acid catabolic process;0.0424770059291789!GO:0051049;regulation of transport;0.0429216110126334!GO:0035035;histone acetyltransferase binding;0.0430471490337341!GO:0005838;proteasome regulatory particle (sensu Eukaryota);0.0432678401649222!GO:0016747;transferase activity, transferring groups other than amino-acyl groups;0.0433619859516864!GO:0001889;liver development;0.0434115600955046!GO:0004004;ATP-dependent RNA helicase activity;0.0434115600955046!GO:0004563;beta-N-acetylhexosaminidase activity;0.043416816093658!GO:0006007;glucose catabolic process;0.0434277303530248!GO:0006595;polyamine metabolic process;0.0436180784716014!GO:0008283;cell proliferation;0.0443888122034401!GO:0004185;serine carboxypeptidase activity;0.0450391060778025!GO:0043065;positive regulation of apoptosis;0.0453068656943353!GO:0007049;cell cycle;0.0456874218986543!GO:0006534;cysteine metabolic process;0.0458450136476353!GO:0005539;glycosaminoglycan binding;0.0459139881472534!GO:0008147;structural constituent of bone;0.0465497325743208!GO:0005096;GTPase activator activity;0.0465497325743208!GO:0009890;negative regulation of biosynthetic process;0.0469443584041292!GO:0001725;stress fiber;0.0471657367949809!GO:0032432;actin filament bundle;0.0471657367949809!GO:0016721;oxidoreductase activity, acting on superoxide radicals as acceptor;0.0473162737059521!GO:0004784;superoxide dismutase activity;0.0473162737059521!GO:0005100;Rho GTPase activator activity;0.0479051640651027!GO:0006642;triacylglycerol mobilization;0.0487590185152018!GO:0009607;response to biotic stimulus;0.0488387134799287!GO:0005832;chaperonin-containing T-complex;0.0488647963606586!GO:0005542;folic acid binding;0.0488647963606586!GO:0048646;anatomical structure formation;0.0491824766366303
|sample_id=10008
|sample_id=10008
|sample_note=
|sample_note=
Line 76: Line 78:
|sample_tissue=whole body
|sample_tissue=whole body
|top_motifs=NR1H4:4.33669576105;HLF:4.25349855833;AR:3.55803759212;HNF1A:3.07291260649;NFIL3:2.85179065936;FOXA2:2.79295555977;HNF4A_NR2F1,2:2.5897924603;FOX{F1,F2,J1}:2.46730009914;NFIX:2.34813125642;ESRRA:2.24904849638;RXR{A,B,G}_{NR1H2,PPAR}dimers:1.99247378841;TBP:1.89586746526;FOX{D1,D2}:1.79279189028;PAX1,9:1.78413894012;IRF7:1.69728095698;STAT2,4,6:1.55317055459;NR3C1:1.47320804567;JUN:1.46096487756;bHLH_family:1.43062490842;ESR1:1.36419431699;NR5A1,2:1.36088443716;NKX3-2:1.35138098019;TBX4,5:1.30777138852;MYB:1.24394962771;SNAI1..3:1.18919076864;T:1.09120619869;NR6A1:1.07178004575;CEBPA,B_DDIT3:1.05101438243;PPARG:1.04861708139;NFE2L1:1.0080353541;ZEB1:1.00445087371;ONECUT1,2:0.890146825116;SOX17:0.882358602252;MYOD1:0.839293668886;HAND1,2:0.794489525797;RFX1:0.790620460053;FOXM1:0.711017747061;FOXO1,3,4:0.66449693304;DMAP1_NCOR{1,2}_SMARC:0.618011784381;ATF6:0.561571608976;FOXN1:0.456465258133;TFCP2:0.376434025573;ZBTB6:0.373479008906;PDX1:0.372884397085;TLX1..3_NFIC{dimer}:0.35508229065;RFX2..5_RFXANK_RFXAP:0.337004398854;ARNT_ARNT2_BHLHB2_MAX_MYC_USF1:0.336343583965;PAX6:0.30139817992;PBX1:0.246262444348;FOSL2:0.21371876839;GATA6:0.21119316386;CUX2:0.198509001121;PAX5:0.12077581422;TP53:0.11712987743;ADNP_IRX_SIX_ZHX:0.111844497456;RXRA_VDR{dimer}:0.0969844177456;IRF1,2:0.086123589089;LMO2:0.0841818488891;GZF1:0.066582722117;TLX2:0.0654242590937;GCM1,2:0.014123252449;RBPJ:-0.0178011507238;MYBL2:-0.026462208928;HSF1,2:-0.0348520219673;MAFB:-0.042848048999;REST:-0.0568636076502;ATF5_CREB3:-0.101480400792;SRF:-0.130370723471;NFY{A,B,C}:-0.16718141828;ZNF148:-0.186796491513;LEF1_TCF7_TCF7L1,2:-0.19074552671;TFAP4:-0.197889059456;HOX{A5,B5}:-0.232269196609;STAT1,3:-0.24527216939;MEF2{A,B,C,D}:-0.249491335677;FOS_FOS{B,L1}_JUN{B,D}:-0.266039995085;HOXA9_MEIS1:-0.278472462782;OCT4_SOX2{dimer}:-0.308349911422;GTF2A1,2:-0.313896086094;HMGA1,2:-0.32049719811;RXR{A,B,G}:-0.332669194721;XCPE1{core}:-0.351560045467;NKX2-2,8:-0.364264931338;MYFfamily:-0.367932024705;POU6F1:-0.375761789312;ATF4:-0.379410789966;POU2F1..3:-0.384610499622;ETS1,2:-0.388736769453;SOX5:-0.3904423467;HIC1:-0.393678246847;ATF2:-0.394759549377;TEAD1:-0.420157086187;RUNX1..3:-0.443259282351;TGIF1:-0.480723023818;MTF1:-0.491150002144;GFI1:-0.494573945538;GFI1B:-0.506520278378;ALX1:-0.511993609052;NHLH1,2:-0.532181437146;PATZ1:-0.536308538171;TFAP2{A,C}:-0.540003977572;SREBF1,2:-0.566521214282;FOXL1:-0.569271896245;NFKB1_REL_RELA:-0.571932657702;SP1:-0.597988583849;SPI1:-0.654746679318;HMX1:-0.676229869058;MED-1{core}:-0.676370379993;PAX8:-0.725167035386;NFE2:-0.735415851694;TFAP2B:-0.738796401661;NKX2-3_NKX2-5:-0.748968263641;EBF1:-0.764639918753;HOX{A4,D4}:-0.770620269692;HIF1A:-0.790849855458;ALX4:-0.79118371793;GTF2I:-0.79330664257;POU1F1:-0.805177127056;NKX6-1,2:-0.82336810693;CREB1:-0.834009175763;MAZ:-0.834651704924;BREu{core}:-0.835698203156;ZNF423:-0.851345994872;FOXQ1:-0.856409412273;FOXD3:-0.864119753122;ZIC1..3:-0.917493557595;HBP1_HMGB_SSRP1_UBTF:-0.940291169782;NFATC1..3:-0.942060602367;NFE2L2:-0.95220800657;ARID5B:-0.966008468766;NANOG{mouse}:-0.979335195522;E2F1..5:-0.979897611898;ZNF238:-0.98710540376;EGR1..3:-1.02432616906;BACH2:-1.02674837148;MTE{core}:-1.04734763674;AHR_ARNT_ARNT2:-1.06486559386;STAT5{A,B}:-1.07114664787;ELF1,2,4:-1.07164639549;FOX{I1,J2}:-1.07653611903;ZFP161:-1.10303228254;KLF4:-1.10442660167;GLI1..3:-1.11415315313;HES1:-1.1246657131;BPTF:-1.14440620284;SMAD1..7,9:-1.18720751242;NRF1:-1.2074196881;EVI1:-1.2267864087;LHX3,4:-1.24279715437;SPIB:-1.25443169011;TOPORS:-1.26694541193;SOX{8,9,10}:-1.27152785238;MZF1:-1.2882140366;YY1:-1.30499751351;DBP:-1.3426538005;POU5F1:-1.34668217689;PRRX1,2:-1.43918159185;GATA4:-1.44711228704;SPZ1:-1.45506991296;POU3F1..4:-1.45954774903;UFEwm:-1.4734801021;TEF:-1.59955410566;IKZF1:-1.62320823931;RORA:-1.66208637229;ELK1,4_GABP{A,B1}:-1.70000092092;RREB1:-1.73982486753;CRX:-1.81581476103;IKZF2:-1.81880687721;PRDM1:-1.82292155247;PITX1..3:-1.8368096744;TAL1_TCF{3,4,12}:-1.85339679704;SOX2:-1.85952768768;CDX1,2,4:-1.89243541765;TFDP1:-1.97969211231;FOXP1:-1.98061070862;CDC5L:-2.00426036186;PAX2:-2.00630110606;EN1,2:-2.01561084636;NKX2-1,4:-2.01611919892;ZNF143:-2.02062602798;VSX1,2:-2.1852943972;NKX3-1:-2.38793852499;PAX4:-2.48679314426;EP300:-2.61189532573;ZBTB16:-2.70527280238;NANOG:-2.7773449805;FOXP3:-2.87663867774;ZNF384:-2.97176325185;AIRE:-3.09194490831
|top_motifs=NR1H4:4.33669576105;HLF:4.25349855833;AR:3.55803759212;HNF1A:3.07291260649;NFIL3:2.85179065936;FOXA2:2.79295555977;HNF4A_NR2F1,2:2.5897924603;FOX{F1,F2,J1}:2.46730009914;NFIX:2.34813125642;ESRRA:2.24904849638;RXR{A,B,G}_{NR1H2,PPAR}dimers:1.99247378841;TBP:1.89586746526;FOX{D1,D2}:1.79279189028;PAX1,9:1.78413894012;IRF7:1.69728095698;STAT2,4,6:1.55317055459;NR3C1:1.47320804567;JUN:1.46096487756;bHLH_family:1.43062490842;ESR1:1.36419431699;NR5A1,2:1.36088443716;NKX3-2:1.35138098019;TBX4,5:1.30777138852;MYB:1.24394962771;SNAI1..3:1.18919076864;T:1.09120619869;NR6A1:1.07178004575;CEBPA,B_DDIT3:1.05101438243;PPARG:1.04861708139;NFE2L1:1.0080353541;ZEB1:1.00445087371;ONECUT1,2:0.890146825116;SOX17:0.882358602252;MYOD1:0.839293668886;HAND1,2:0.794489525797;RFX1:0.790620460053;FOXM1:0.711017747061;FOXO1,3,4:0.66449693304;DMAP1_NCOR{1,2}_SMARC:0.618011784381;ATF6:0.561571608976;FOXN1:0.456465258133;TFCP2:0.376434025573;ZBTB6:0.373479008906;PDX1:0.372884397085;TLX1..3_NFIC{dimer}:0.35508229065;RFX2..5_RFXANK_RFXAP:0.337004398854;ARNT_ARNT2_BHLHB2_MAX_MYC_USF1:0.336343583965;PAX6:0.30139817992;PBX1:0.246262444348;FOSL2:0.21371876839;GATA6:0.21119316386;CUX2:0.198509001121;PAX5:0.12077581422;TP53:0.11712987743;ADNP_IRX_SIX_ZHX:0.111844497456;RXRA_VDR{dimer}:0.0969844177456;IRF1,2:0.086123589089;LMO2:0.0841818488891;GZF1:0.066582722117;TLX2:0.0654242590937;GCM1,2:0.014123252449;RBPJ:-0.0178011507238;MYBL2:-0.026462208928;HSF1,2:-0.0348520219673;MAFB:-0.042848048999;REST:-0.0568636076502;ATF5_CREB3:-0.101480400792;SRF:-0.130370723471;NFY{A,B,C}:-0.16718141828;ZNF148:-0.186796491513;LEF1_TCF7_TCF7L1,2:-0.19074552671;TFAP4:-0.197889059456;HOX{A5,B5}:-0.232269196609;STAT1,3:-0.24527216939;MEF2{A,B,C,D}:-0.249491335677;FOS_FOS{B,L1}_JUN{B,D}:-0.266039995085;HOXA9_MEIS1:-0.278472462782;OCT4_SOX2{dimer}:-0.308349911422;GTF2A1,2:-0.313896086094;HMGA1,2:-0.32049719811;RXR{A,B,G}:-0.332669194721;XCPE1{core}:-0.351560045467;NKX2-2,8:-0.364264931338;MYFfamily:-0.367932024705;POU6F1:-0.375761789312;ATF4:-0.379410789966;POU2F1..3:-0.384610499622;ETS1,2:-0.388736769453;SOX5:-0.3904423467;HIC1:-0.393678246847;ATF2:-0.394759549377;TEAD1:-0.420157086187;RUNX1..3:-0.443259282351;TGIF1:-0.480723023818;MTF1:-0.491150002144;GFI1:-0.494573945538;GFI1B:-0.506520278378;ALX1:-0.511993609052;NHLH1,2:-0.532181437146;PATZ1:-0.536308538171;TFAP2{A,C}:-0.540003977572;SREBF1,2:-0.566521214282;FOXL1:-0.569271896245;NFKB1_REL_RELA:-0.571932657702;SP1:-0.597988583849;SPI1:-0.654746679318;HMX1:-0.676229869058;MED-1{core}:-0.676370379993;PAX8:-0.725167035386;NFE2:-0.735415851694;TFAP2B:-0.738796401661;NKX2-3_NKX2-5:-0.748968263641;EBF1:-0.764639918753;HOX{A4,D4}:-0.770620269692;HIF1A:-0.790849855458;ALX4:-0.79118371793;GTF2I:-0.79330664257;POU1F1:-0.805177127056;NKX6-1,2:-0.82336810693;CREB1:-0.834009175763;MAZ:-0.834651704924;BREu{core}:-0.835698203156;ZNF423:-0.851345994872;FOXQ1:-0.856409412273;FOXD3:-0.864119753122;ZIC1..3:-0.917493557595;HBP1_HMGB_SSRP1_UBTF:-0.940291169782;NFATC1..3:-0.942060602367;NFE2L2:-0.95220800657;ARID5B:-0.966008468766;NANOG{mouse}:-0.979335195522;E2F1..5:-0.979897611898;ZNF238:-0.98710540376;EGR1..3:-1.02432616906;BACH2:-1.02674837148;MTE{core}:-1.04734763674;AHR_ARNT_ARNT2:-1.06486559386;STAT5{A,B}:-1.07114664787;ELF1,2,4:-1.07164639549;FOX{I1,J2}:-1.07653611903;ZFP161:-1.10303228254;KLF4:-1.10442660167;GLI1..3:-1.11415315313;HES1:-1.1246657131;BPTF:-1.14440620284;SMAD1..7,9:-1.18720751242;NRF1:-1.2074196881;EVI1:-1.2267864087;LHX3,4:-1.24279715437;SPIB:-1.25443169011;TOPORS:-1.26694541193;SOX{8,9,10}:-1.27152785238;MZF1:-1.2882140366;YY1:-1.30499751351;DBP:-1.3426538005;POU5F1:-1.34668217689;PRRX1,2:-1.43918159185;GATA4:-1.44711228704;SPZ1:-1.45506991296;POU3F1..4:-1.45954774903;UFEwm:-1.4734801021;TEF:-1.59955410566;IKZF1:-1.62320823931;RORA:-1.66208637229;ELK1,4_GABP{A,B1}:-1.70000092092;RREB1:-1.73982486753;CRX:-1.81581476103;IKZF2:-1.81880687721;PRDM1:-1.82292155247;PITX1..3:-1.8368096744;TAL1_TCF{3,4,12}:-1.85339679704;SOX2:-1.85952768768;CDX1,2,4:-1.89243541765;TFDP1:-1.97969211231;FOXP1:-1.98061070862;CDC5L:-2.00426036186;PAX2:-2.00630110606;EN1,2:-2.01561084636;NKX2-1,4:-2.01611919892;ZNF143:-2.02062602798;VSX1,2:-2.1852943972;NKX3-1:-2.38793852499;PAX4:-2.48679314426;EP300:-2.61189532573;ZBTB16:-2.70527280238;NANOG:-2.7773449805;FOXP3:-2.87663867774;ZNF384:-2.97176325185;AIRE:-3.09194490831
|xref=
}}
}}

Revision as of 15:21, 27 June 2012


Name:Universal RNA - Mouse Normal Tissues Biochain, pool1
Species:Mouse (Mus musculus)
Library ID:{{{library_id}}}
Sample type:{{{sample_category}}}
Genomic View: UCSC
CAGEd-oPOSSUM:link
Additional information
Sample information
strainBalb/C
tissuewhole body
dev stage6-8 weeks old adult
sexmixed
ageNA
cell typeCELL MIXTURE - tissue sample
cell lineNA
companyBiochain
collaborationFANTOM5 OSC CORE (contact: Al Forrest)
External link for information[{{{sample_info_link}}} {{{sample_info_link}}}]
RNA information
lot numberB307206
catalog numberCat:R4334566-1
sample typetotal RNA
extraction protocol (Details)OP-RNA-extraction-totalRNA-TRIzol-isopropanol-v1.0
Download raw sequence, BAM & CTSS
Mm9
BAMCTSS
[{{{mm9bam}}} download][{{{mm9ctss}}} donwload]
Mm10
BAMCTSS
[{{{mm10bam}}} download][{{{mm10ctss}}} donwload]


Relative expression to median (log10)

Transcription factors with enriched expression in this sampleRanked list of transcription factor promoter expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed.



Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed. <br>Analyst:NA <br><br>link to dataset.<br>data

CNhs10613

00.196
10.047
100
1000
10000.163
1001-0.0121
1002-0.0475
10030.00475
10040
10050.261
10060.252
1007-0.0772
10081.686
10090.0312
101-0.0509
10100
10110.0975
10120
10130.349
1014-0.0851
1015-0.237
1016-0.251
10170
10180.227
10190.047
1020
10200
1021-0.00173
10220.439
10230
10240.0834
10250.246
10260.255
10270.0141
10280
1029-0.0678
103-0.03
10300.047
1031-0.325
10320.174
10330.0141
10340.395
10350.047
1036-0.272
10370.128
1038-0.0576
10390.423
1040.047
1040-0.126
10410.353



Repeat families with enriched expression in this sample<b>Summary:</b>Ranked list of repeat family expression in this sample relative tothe median expression in the FANTOM5 collection is shown. Value is log10transformed.<br><b>Analyst:</b>NA<br><br>link to dataset.<br>data no result for this sample


TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample

JASPAR motifs<b>Summary:</b>Association of JASPAR motif to the promoter expression in thissample. Pearson's correlation between the number of TFBSs estimated byusing the position-weight matrix for each promoter and its expression isexpressed as Z-score by taking the ones based on random position-weightmatrix, and the tail probability of the normal distribution correspondingto the Z-score is taken as the resulting P-value. Lower P-value indicatesmore (non-random) association of the motif to promoter expression<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data

library id: CNhs10613

Jaspar motifP-value
MA0002.20.0871
MA0003.10.0227
MA0004.10.817
MA0006.10.255
MA0007.10.0366
MA0009.10.264
MA0014.10.617
MA0017.12.23801e-19
MA0018.20.819
MA0019.10.941
MA0024.10.0065
MA0025.10.0225
MA0027.10.186
MA0028.10.0665
MA0029.10.577
MA0030.10.035
MA0031.10.0166
MA0035.20.0282
MA0038.10.594
MA0039.20.087
MA0040.10.0943
MA0041.10.291
MA0042.10.719
MA0043.10.371
MA0046.11.05311e-86
MA0047.22.05608e-4
MA0048.10.902
MA0050.10.495
MA0051.10.162
MA0052.10.363
MA0055.10.94
MA0057.10.367
MA0058.10.964
MA0059.10.448
MA0060.10.327
MA0061.10.923
MA0062.20.00122
MA0065.23.06091e-16
MA0066.10.104
MA0067.10.413
MA0068.10.81
MA0069.10.499
MA0070.10.857
MA0071.10.0476
MA0072.10.563
MA0073.10.965
MA0074.10.373
MA0076.10.0183
MA0077.10.937
MA0078.10.0499
MA0079.20.261
MA0080.20.771
MA0081.10.0469
MA0083.10.737
MA0084.10.73
MA0087.10.948
MA0088.10.638
MA0090.10.176
MA0091.10.84
MA0092.10.334
MA0093.10.959
MA0099.20.84
MA0100.15.62472e-4
MA0101.10.292
MA0102.20.841
MA0103.10.00259
MA0104.20.714
MA0105.10.232
MA0106.10.948
MA0107.10.173
MA0108.29.36828e-5
MA0111.10.412
MA0112.22.3113e-6
MA0113.10.123
MA0114.14.07977e-19
MA0115.12.63916e-12
MA0116.10.102
MA0117.10.782
MA0119.10.0234
MA0122.10.998
MA0124.10.332
MA0125.10.195
MA0131.10.555
MA0135.10.7
MA0136.10.174
MA0137.20.7
MA0138.20.0153
MA0139.10.274
MA0140.10.413
MA0141.18.21654e-5
MA0142.10.805
MA0143.10.127
MA0144.10.5
MA0145.10.0251
MA0146.10.0411
MA0147.10.71
MA0148.11.01109e-4
MA0149.10.168
MA0150.10.125
MA0152.10.689
MA0153.14.56784e-52
MA0154.10.0365
MA0155.10.388
MA0156.10.0557
MA0157.10.0683
MA0159.10.00336
MA0160.19.37665e-6
MA0162.10.195
MA0163.10.00111
MA0164.10.629
MA0258.11.17331e-4
MA0259.10.588



FANTOM5 phase1 novel unique motifs<b>Summary:</b>Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data

library id: CNhs10613

Novel motifP-value
10.148
100.367
1000.541
1010.304
1020.598
1030.163
1040.345
1050.608
1060.0365
1070.0696
1080.769
1090.0937
110.112
1100.149
1110.143
1120.0194
1130.638
1140.0265
1150.523
1160.159
1170.381
1180.436
1190.126
120.756
1200.588
1210.0966
1220.461
1230.636
1240.974
1250.902
1260.225
1270.794
1280.0775
1290.701
130.0263
1300.908
1310.409
1320.362
1330.447
1340.93
1350.372
1360.143
1370.949
1380.855
1390.0513
140.549
1400.962
1410.747
1420.908
1430.837
1440.929
1450.0897
1460.204
1470.477
1480.982
1490.47
150.172
1500.232
1510.322
1520.0902
1530.856
1540.811
1550.823
1567.11735e-11
1570.564
1580.243
1590.334
1600.472
1610.383
1620.248
1630.93
1640.369
1650.617
1660.516
1670.993
1680.539
1696.68224e-4
170.071
180.866
190.0566
20.52
200.978
210.651
220.146
230.26
240.0563
250.424
260.0772
270.699
280.333
290.332
30.179
300.474
310.363
320.0385
330.447
340.47
350.322
360.18
370.128
380.69
390.332
40.829
400.0802
410.0195
420.518
430.151
440.0708
450.297
460.191
470.14
480.137
490.164
50.266
500.67
510.536
520.159
530.99
540.496
550.764
560.6
570.944
580.204
590.0835
60.897
600.102
610.642
620.0971
630.11
640.476
650.441
660.795
670.164
680.189
690.981
70.198
700.0464
710.162
720.36
730.16
740.323
750.107
760.707
770.108
780.525
790.728
80.00662
800.491
810.829
820.0408
830.209
840.183
850.0257
860.22
870.0152
880.643
890.117
90.702
900.236
910.217
920.177
930.923
940.901
950.21
960.484
970.0779
980.337
990.0921



de novo motifs identified by HOMER in promoters active in this sample<b>Summary:</b>The result of HOMER in this sample is shown.<br><b>Analyst:</b>NA <br> library id: CNhs10613


FANTOM5 (FF) ontology

Direct parent terms

has_quality relathionship
PATO:0000461

Ancestor terms (non development)<b>Summary:</b>Connected ontology terms with is_a, part_of or located_in relationship <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source data<br>data

UBERON: Anatomy
0000479 (tissue)
0000061 (anatomical structure)
0000465 (material anatomical entity)
0001062 (anatomical entity)

FF: FANTOM5
NA

Ancestor terms (development)<b>Summary:</b>Connected ontology terms with develops_from, derives_from or preceded_by relationship <br><b>Analyst:</b> Hideya Kawaji <br><br>link to source data<br>data
NA

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=FF:10008-101B6&oldid=1839697"